Home>>Lipids>> Sphingolipids>>C16 3'-sulfo Galactosylceramide (d18:1/16:0)

C16 3'-sulfo Galactosylceramide (d18:1/16:0) (Synonyms: (3'-sulfo)Galβ-Cer(d18:1/16:0), N-Hexadecanoyl-Sulfatide, C16 Sulfatide)

Catalog No.GC43026

C16 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids.

Products are for research use only. Not for human use. We do not sell to patients.

C16 3'-sulfo Galactosylceramide (d18:1/16:0) Chemical Structure

Cas No.: 89771-78-8

Size Price Stock Qty
1mg
$735.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

C16 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. It is one of the most abundant sulfatides found in porcine brain and plasma. Levels of short-chain sulfatides, including C16-C20 3'-sulfo galactosylceramides, decrease throughout development in mice. C16 3'-sulfo Galactosylceramide inhibits retinal ganglion cell neurite outgrowth in vitro. It is increased in dried urine spots and dried blood spots from patients with metachromatic leukodystrophy (MLD). C16 3'-sulfo Galactosylceramide has been used as an internal standard for the quantification of sulfatides in rat cerebellum and isolated white matter from patients with multiple sclerosis.

Reviews

Review for C16 3'-sulfo Galactosylceramide (d18:1/16:0)

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for C16 3'-sulfo Galactosylceramide (d18:1/16:0)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.